Rimsevicius Laurynas, Sukackiene Diana, Tamulyte Giedre, Kirkilaite Greta, Miglinas Marius
Faculty of Medicine, Vilnius University; Nephrology Center, Vilnius University Hospital Santariskiu klinikos; Vilnius, Lithuania.
Iran J Kidney Dis. 2017 Jan;11(1):70-73.
Psoriasis vulgaris is not frequently seen in patients with renal replacement therapy, especially in patients on peritoneal dialysis. Dialysis also has been reported to improve psoriatic skin lesions with a much higher response rate for peritoneal dialysis than haemodialysis. Conversely, we present a case of a man who developed psoriasis after 16 months of peritoneal dialysis. Discontinuation of icodextrin as a possible factor provoking systemic inflammation had no impact on the course of the disease. In this report, we review the existing studies and counsel caution against optimistic expectations of benefits from dialysis in patients with psoriasis.
寻常型银屑病在接受肾脏替代治疗的患者中并不常见,尤其是在接受腹膜透析的患者中。据报道,透析也可改善银屑病皮损,腹膜透析的反应率远高于血液透析。相反,我们报告了一例男性患者,在腹膜透析16个月后出现银屑病。停用可能引发全身炎症的艾考糊精对疾病进程并无影响。在本报告中,我们回顾了现有研究,并提醒不要对银屑病患者透析的益处抱有乐观期望。